Utility of exhaled nitric oxide in the diagnosis and management of asthma

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 1, 2010, Pages 42-47

  Majid, Hashir ^a   Kao, Christina ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CHILDREN S NUTRITION RESEARCH CENTER   (United States)

Author keywords

Asthma; Diagnosis; Fraction of nitric oxide in exhaled air; Management

Indexed keywords

CORTICOSTEROID; MONTELUKAST; NITRIC OXIDE;

ALGORITHM; ASTHMA; CLINICAL TRIAL; DECISION MAKING; DISEASE EXACERBATION; EXPIRED AIR; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MAINTENANCE THERAPY; REVIEW; SCREENING;

ALGORITHMS; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; HUMANS; NITRIC OXIDE;

EID: 74549216073     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328332ca46     Document Type: Review

References (63)

1. Global Initiative for Asthma. www.ginasthma.com (accessed July 2009).
2. Lex C, Ferreira F, Zacharasiewicz A, et al. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med 2006; 174:1286-1291.
3. Warke TJ, Fitch PS, Brown V, et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002; 57:383-387.
4. van den Toorn LM, Overbeek SE, de Jongste JC, et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001; 164:2107-2113.
5. Payne DN, Adcock IM, Wilson NM, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001; 164 (8 Pt 1):1376-1381.
6. Berlyne GS, Parameswaran K, Kamada D, et al. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000; 106:638-644.
7. Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53:91-95.
8. Strunk RC, Szefler SJ, Phillips BR, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003; 112:883-892.
9. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526. (Pubitemid 17085822)
10. Musial A, Eissa NT. Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J Biol Chem 2001; 276:24268-24273.
11. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342:1510-1513.
12. Lane C, Knight D, Burgess S, et al. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 2004; 59:757-760.
13. Guo FH, Comhair SA, Zheng S, et al. Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and posttranslational regulation of NO synthesis. J Immunol 2000; 164:5970-5980.
14. Dupont LJ, Rochette F, Demedts MG, Verleden GM. Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998; 157 (3 Pt 1): 894-898.
15. Zietkowski Z, Bodzenta-Lukaszyk A, Tomasiak MM, et al. Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients. J Investig Allergol Clin Immunol 2006; 16:239-246.
16. Covar RA, Szefler SJ, Martin RJ, et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003; 142:469-475
17. Stirling RG, Kharitonov SA, Campbell D, et al. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Asthma and Allergy Group. Thorax 1998; 53:1030-1034.
18. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-930.
19. Linn WS, Rappaport EB, Berhane KT, et al. Exhaled nitric oxide in a population- based study of southern California schoolchildren. Respir Res 2009; 10:28.
20. Travers J, Marsh S, Aldington S, et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 2007; 176:238-242.
21. Olivieri M, Talamini G, Corradi M, et al. Reference values for exhaled nitric oxide (reveno) study. Respir Res 2006; 7:94.
22. Buchvald F, Baraldi E, Carraro S, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005; 115:1130-1136.
23. Olin AC, Bake B, Toren K. Fraction of exhaled nitric oxide at 50 ml/s: reference values for adult lifelong never-smokers. Chest 2007; 131:1852-1856.
24. Kovesi T, Kulka R, Dales R. Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. Chest 2008; 133:169-175.
25. Olin AC, Rosengren A, Thelle DS, et al. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006; 130:1319-1325.
26. Malmberg LP, Petays T, Haahtela T, et al. Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol 2006; 41:635-642.
27. Taylor DR, Mandhane P, Greene JM, et al. Factors affecting exhaled nitric oxide measurements: the effect of sex. Respir Res 2007; 8:82.
28. Olivieri M, Corradi M, Malerba M. Gender and exhaled nitric oxide. Chest 2007; 132:1410; author reply.
29. Persson MG, Zetterstrom O, Agrenius V, et al. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994; 343:146-147.
30. Kharitonov SA, Robbins RA, Yates D, et al. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152:609-612.
31. Kharitonov SA, Yates D, Barnes PJ. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995; 8:295-297.
32. Sivan Y, Gadish T, Fireman E, Soferman R. The use of exhaled nitric oxide in the diagnosis of asthma in school children. J Pediatr 2009; 155:211-216.
33. Schneider A, Tilemann L, Schermer T, et al. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement - results of a prospective diagnostic study. Respir Res 2009; 10:15.
34. Respir Res 2009; 10(1):64.
35. Kostikas K, Papaioannou AI, Tanou K, et al. Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season. Chest 2008; 133:906-913.
36. Bommarito L, Migliore E, Bugiani M, et al. Exhaled nitric oxide in a population sample of adults. Respiration 2008; 75:386-392.
37. Miedinger D, Chhajed PN, Tamm M, et al. Diagnostic tests for asthma in firefighters. Chest 2007; 131:1760-1767.
38. Berkman N, Avital A, Breuer R, et al. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax 2005; 60:383-388.
39. Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 2004; 169:473-478.
40. Dupont LJ, Demedts MG, Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003; 123:751-756.
41. Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax 2003; 58:494-499.
42. van Asch CJ, Balemans WA, Rovers MM, et al. Atopic disease and exhaled nitric oxide in an unselected population of young adults. Ann Allergy Asthma Immunol 2008; 100:59-65.
43. Kovesi T, Dales R. Exhaled nitric oxide and respiratory symptoms in a community sample of school aged children. Pediatr Pulmonol 2008; 43: 1198-1205.
44. Ho LP, Wood FT, Robson A, et al. Atopy influences exhaled nitric oxide levels in adult asthmatics. Chest 2000; 118:1327-1331.
45. Sippel JM, Holden WE, Tilles SA, et al. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol 2000; 106:645-650.
46. Crater SE, Peters EJ, Martin ML, et al. Expired nitric oxide and airway obstruction in asthma patients with an acute exacerbation. Am J Respir Crit Care Med 1999; 159:806-811.
47. Harkins MS, Fiato KL, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma 2004; 41:471-476.
48. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164:738-743.
49. Gelb AF, Flynn Taylor C, Shinar CM, et al. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006; 129:1492-1499.
50. Fritsch M, Uxa S, Horak F Jr, et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 2006; 41:855-862.
51. Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J 2008; 31:539-546.
52. Michils A, Louis R, Peche R, et al. Exhaled nitric oxide as a marker of asthma control in smoking patients. Eur Respir J 2009; 33:1295-1301.
53. Menzies D, Jackson C, Mistry C, et al. Symptoms, spirometry, exhaled nitric oxide, and asthma exacerbations in clinical practice. Ann Allergy Asthma Immunol 2008; 101:248-255.
54. Gruchalla RS, Sampson HA, Matsui E, et al. Asthma morbidity among innercity adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence. J Allergy Clin Immunol 2009; 124:213-221; e1.
55. Little SA, Chalmers GW, MacLeod KJ, et al. Noninvasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000; 55:232-234.
56. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153:454-457.
57. Ghiro L, Zanconato S, Rampon O, et al. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children. Eur Respir J 2002; 20:630-634.
58. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 2005; 172:831-836.
59. Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008; 372:1065-1072.
60. Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007; 176:231-237.
61. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352:2163-2173.
62. de Jongste JC, Carraro S, Hop WC, Baraldi E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med 2009; 179:93-97.
63. Petsky HL, Cates CJ, Li AM, et al. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2008:CD006340.